IL-1β inhibits IFN-γ-induced class II MHC expression by suppressing transcription of the class II transactivator gene

Journal of Immunology

Volumn 162, Issue 2, 1999, Pages 886-896

  Rohn, Wolfgang ^a   Tang, Li Ping ^a   Dong, Yuanshu ^a   Benveniste, Etty N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; STAT1 PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; ASTROCYTOMA; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ASTROCYTOMA; DNA-BINDING PROTEINS; GENES, MHC CLASS II; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE II; INTERLEUKIN-1; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0344938399     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Benacerraf, B. 1981. Role of MHC gene products in immune regulation. Science 212:1229.
2. Rohn, W. M., Y.-J. Lee, and E. N. Benveniste, 1996. Regulation of class II MHC expression. Crit. Rev. Immunol. 16:311.
3. Wekerle, H. 1995. Antigen presentation by central nervous system glia. In: Neuroglia, H. Kettenmann and B. R. Ransom, eds. Oxford Press, New York, p. 685.
4. Martin, R., and H. McFarland. 1996. Experimental immunotherapies for multiple sclerosis. Springer Semin. Immunopathol. 18:1.
5. Hofman, F. M., R. VonHanwher, C. Dinarello, S. Mizel, D. Hinton, and J. E. Merrill. 1986. Immunoregulatory molecules and IL-2 receptors identified in multiple sclerosis brain. J. Immunol. 136:3239.
6. Bö, L., S. Mörk, P. A. Kong, H. Nyland, C. A. Pardo, and B. D. Trapp. 1994. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelial in active multiple sclerosis lesions. J. Neuroimmunol. 51:135.
7. McCombe, P. A., J. de Jersey, and M. P. Pender. 1994. Inflammatory cells, microglia and MHC class II antigen-positive cells in the spinal cord of Lewis rats with acute and chronic relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 51:153.
8. Lee, S. C., G. R. W. Moore, G. Golenwsky, and C. S. Raine. 1990. Multiple sclerosis: a role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study. J. Neuropathol. Exp. Neurol. 49: 122.
9. Hickey, W. F., J. P. Osborn, and W. M. Kirby. 1985. Expression of la molecules by astrocytes during acute experimental allergic encephalomyelitis in the Lewis rat. Cell. Immunol. 91:528.
10. Matsumoto, Y., K. Kawai, and M. Fujiwara. 1989. In situ la expression on brain cells in the rat: autoimmune encephalomyelitis-resistant strain (BN) and susceptible strain (Lewis) compared. Immunology 66:621.
11. Abdulkadir, S. A., and S. J. Ono. 1995. How are class II MHC genes turned on and off? FASEB J. 9:1429.
12. Reith, W., M. Kobr, P. Emery, B. Durand, C.-A. Siegrist, and B. Mach. 1994. Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters. J. Biol. Chem. 269:20020.
13. Reith, W., C.-A. Siegrist, B. Durand, E. Barras, and B. Mach. 1994. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA 91:554.
14. Riley, J. L., and J. M. Boss. 1993. Class II MHC transcriptional mutants are defective in higher order complex formation. J. Immunol. 151:6942.
15. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135.
16. Steimle, V., C.-A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 265:106.
17. Chin, K.-C., C. Mao, C. Skinner, J. L. Riley, K. L. Wright, C. S. Moreno, G. R. Stark, J. M. Boss, and J. P.-Y. Ting. 1994. Molecular analysis of G1B and G3A IFN-γ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity 1:687.
18. Chang, C.-H., J. D. Fontes, M. Peterlin, and R. A. Flavell. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367.
19. Riley, J. L., S. D. Westerheide, J. A. Price, J. A. Brown, and J. M. Boss. 1995. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2:533.
20. Zhou, H., and L. H. Glimcher. 1995. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2:545.
21. Mahanta, S. K., T. Scholl, F.-C. Yang, and J. L. Strominger. 1997. Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein. Proc. Natl. Acad. Sci. USA 94:6324.
22. Scholl, T., S. K. Mahanta, and J. L. Strominger. 1997. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. USA 94:6330.
23. Lee, Y.-J., and E. N. Benveniste. 1996. STAT-1 α expression is involved in IFN-γ induction of the class II transactivator and class II MHC genes. J. Immunol. 157:1559.
24. Lee, Y.-J., Y. Han, H.-T. Lu, V. Nguyen, H. Qin, P. H. Howe, B. A. Hocevar, J. M. Boss, R. M. Ransohoff, and E. N. Benveniste. 1997. TGF-β suppresses IFN-γ induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J. Immunol. 158:2065.
25. Chang, C.-H., S. Guerder, S.-C. Hong, W. van Ewijk, and R. A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167.
26. Suzumura, A., M. Sawada, H. Yamamoto, and T. Marunouchi. 1993. Transforming growth factor-β suppresses activation and proliferation of microglia in vitro. J. Immunol. 151:2150.
27. Reimold, A. M., C. J. Kara, J. W. Rooney, and L. H. Glimcher. 1993. Transforming growth factor β1 repression of the HLA-DRα gene is mediated by conserved proximal promoter elements. J. Immunol. 151:4173.
28. Panek, R. B., and E. N. Benveniste. 1995. Class II MHC gene expression in microglia: regulation by the cytokines IFN-γ, TNF-α and TGF-β. J. Immunol. 154:2846.
29. Panek, R. B., Y.-J. Lee, and E. N. Benveniste. 1995. TGF-β suppression of IFN-γ induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2 or STATI α or modification of IFNEX expression. J. Immunol. 154:610.
30. Ling, P. D., M. K. Warren, and S. N. Vogel. 1985. Antagonistic effect of interferon-β on the interferon-γ-induced expression of Ia antigen in murine macrophages. J. Immunol. 135:1857.
31. de Waal Malefyt, R., J. Haanen, H. Spits, M.-G. Roncarolo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915.
32. Frei, K., H. Lins, C. Schwerdel, and A. Fontana. 1994. Antigen presentation in the central nervous system: the inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. J. Immunol. 152:2720.
33. Lu, H.-T., J. L. Riley, G. T. Babcock, M. Huston, G. R. Stark, J. M. Boss, and R. M. Ransohoff. 1995. Interferon (IFN) β acts downstream of IFN-γ-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-γ. J. Exp. Med. 182:1517.
34. Koppelman, B., J. J. Neefjes, J. E. de Vries, and R. de Waal Malefyt. 1997. Interleukin-10 down-regulates MHC class II αβ peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 7:861.
35. Nandan, D., and N. E. Reiner. 1997. TGF-β attenuates the class II transactivator and reveals an accessory pathway of IFN-γ action. J. Immunol. 158: 1095.
36. Piskurich, J. F., Y. Wang, M. W. Linhoff, L. C. White, and J. P.-Y. Ting. 1998. Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-γ. STATI, and TGF-β-regulated expression of the class II transactivator gene. J. Immunol. 160:233.
37. Smith, M. E., D. E. McFarlin, and S. Dhib-Jalbut. 1993. Differential effect of interleukin-1β on Ia expression in astrocytes and microglia. J. Neuroimmunol. 46:97.
38. Cowan, K. P., M. L. Pierce, and S. Dhib-Jalbut. 1991. Interleukin-1β decreases HLA class II expression on a glioblastoma multiforme cell line. J. Neuroimmunal. 33:17.
39. Johnson, W. J., A. Kelley, J. R. Connor, B. J. Dalton, and P. C. Meunier. 1989. Inhibition of IFN-γ-induced Ia antigen expression on synovial fibroblasts by IL-1. J. Immunol. 143:1614.
40. Tanaka, M., and R. M. McCarron. 1990. The inhibitory effect of tumor necrosis factor and interleukin-1 on Ia induction by interferon-γ on endothelial cells from murine central nervous system microvessels. J. Neuroimmunol. 27:209.
41. Winkler, M., and E. N. Benveniste. 1998. Transforming growth factor-β inhibition of cytokine-induced vascular cell adhesion molecule-1 expression in human astrocytes. GLIA 22:171.
42. Shrikant, P., S. J. Lee, I. Kalvakalanu, R. M. Ransohoff, and E. N. Benveniste. 1996. Stimulus-specific inhibition of 1CAM-1 gene expression by TGF-β. J. Immunol. 157:892.
43. Pine, R., T. Decker, D. S. Kessler, D. E. Levy, and J. E. Darnell, Jr. 1990. Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both β interferon- and interferon-stimulated genes but is not a primary transcriptional activator of either. Mol. Cell. Biol. 10:2448.
44. Hou, J., V. Baichwal, and Z. Cao. 1994. Regulatory elements and transcription factors controlling basal and cytokine-induced expression of the gene encoding intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA 91:11641.
45. Muhlethaler-Mottet, A., L. A. Otten, V. Steimle, and B. Mach. 1997. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16:2851.
46. Lee, S. J., J. Y. Park, J. Hou, and E. N. Benveniste. 1999. Transcriptional regulation of the intercellular adhesion molecule-1 gene by proinflammatory cytokines in human astrocytes. GLIA. 25:21.
47. Barnes, D. A., M. Huston, R. Holmes, E. N. Benveniste, V. W. Yong, P. Scholz, and H. D. Perez. 1996. Induction of RANTES expression by astrocytes and astrocytoma cell lines. J. Neuroimmunol. 71:207.
48. Quandt, K., K. Frech, H. Karas, E. Wingender, and T. Werner. 1995. Matlnd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:4878.
49. Meraz, M., J. M. White, K. C. F. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J, K. Riley, A. C. Greenlund, D. Campbell, et al. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431.
50. Muhlethaler-Mottet, A., W. Di Berardino, L. A. Otten, and B. Mach. 1998. Activation of the MHC class II transactivator CIITA by interferon-γ requires cooperative interaction between Stat1 and USF-1. Immunity 8:157.
51. Hobart, M., V. Ramassar, N. Goes, J. Urmson, and P. F. Halloran. 1997. IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J. Immunol. 158:4260.
52. Dinarello, C. A. 1996. Biologic basis for interleukin-1 in disease. Blood 87:2095.
53. Heldin, C.-H., K. Miyazono, and P. ten Dijke. 1997. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465.
54. Dinarello, C. A. 1994. The interleukin-1 family: 10 years of discovery. FASEB J. 8:1314.
55. Benveniste, E. N. 1997. Cytokines and the central nervous system. In Cytokines in Health and Disease. D. G. Remick and J. S. Friedland, eds. Marcel Dekker, New York, pp. 531.
56. Fontana, A., W, Fierz, and H. Wekerle. 1984. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 307:273.
57. Aloisi, F., F. Ria, G. Penna, and L. Adorini. 1998. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J. Immunol. 160:4671.
58. Nikcevich, K. M., K. B. Gordon, L. Tan, S. D. Hurst, J. F. Kroepfl, M. Gardinier, T. A. Barrett, and S. D. Miller. 1997. IFN-γ-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. J. Immunol. 158:614.
59. Tan, L., K. B. Gordon, J. P. Mueller, L. A. Matis, and S. D. Miller. 1998. Presentation of proteolipid protein epitopes and B7-1 -dependent activation of encephalitogenic T cells by IFN-γ-activated SJL/J astrocytes. J. Immunol. 160: 4271.
60. Matsumoto, Y., K. Ohmori, and M. Fujiwara. 1992. Immune regulation by brain cells in the central nervous system: microglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo-mimicking conditions. Immunology 76:209.
61. Weber, F., E. Meinl, F. Aloisi, C. Nevinny-Stickel, E. Albert, H. Wekerle, and R. Hohlfeld. 1994. Human astrocytes are only partially competent antigen presenting cells. Brain 117:59.
62. Gold, R., M. Schmied, U. Tontsch, H. P. Hartung, H. Wekerle, K. V. Toyka, and H. Lassmann. 1996. Antigen presentation by astrocytes primes rat T lymphocytes for apoptotic cell death. Brain 119:651.